Merit Medical Systems, Inc. (NASDAQ:MMSI) Stock Now Rated "Moderate Buy" by Sell-Side Brokerages

Key Points

• Analysts rate Merit Medical Systems a “Moderate Buy”: Eight of 12 covering brokerages recommend buying the stock, while four rate it a hold. The average 12-month price target is $100, above the reported $91.40 share price.
• Recent financial results exceeded expectations: Merit reported quarterly EPS of $1.19 versus the $0.96 consensus estimate, while revenue reached $418.84 million and rose 9.5% year over year.
• Institutional ownership remains very high: Institutional investors hold 99.66% of the company’s stock, with several funds recently initiating or increasing positions.

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI - Get Free Report) have been given an average recommendation of "Moderate Buy" by the twelve brokerages that are covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $100.00.

MMSI has been the topic of a number of analyst reports. Needham & Company LLC reaffirmed a "buy" rating and set a $101.00 price objective on shares of Merit Medical Systems in a report on Tuesday, September 29th. Weiss Ratings upgraded shares of Merit Medical Systems from a "hold (c)" rating to a "hold (c+)" rating in a research note on Monday, October 12th. Piper Sandler increased their target price on shares of Merit Medical Systems from $96.00 to $106.00 and gave the company an "overweight" rating in a report on Friday, July 31st. Canaccord Genuity Group raised their price target on shares of Merit Medical Systems from $85.00 to $94.00 and gave the company a "buy" rating in a research report on Friday, July 31st. Finally, Robert W. Baird set a $98.00 price target on shares of Merit Medical Systems in a report on Friday, July 31st.

Hedge Funds Weigh In On Merit Medical Systems

Several hedge funds have recently modified their holdings of the company. Kilter Group LLC bought a new position in shares of Merit Medical Systems in the second quarter valued at approximately $25,000. Harbor Investment Advisory LLC purchased a new stake in shares of Merit Medical Systems during the second quarter valued at approximately $50,000. IFP Advisors Inc increased its position in shares of Merit Medical Systems by 88.6% during the third quarter. IFP Advisors Inc now owns 694 shares of the medical instruments supplier's stock valued at $60,000 after acquiring an additional 326 shares during the last quarter. Farther Finance Advisors LLC lifted its holdings in Merit Medical Systems by 44.0% during the third quarter. Farther Finance Advisors LLC now owns 890 shares of the medical instruments supplier's stock worth $77,000 after acquiring an additional 272 shares during the period. Finally, State of Wyoming bought a new stake in Merit Medical Systems during the second quarter worth $79,000. Institutional investors own 99.66% of the company's stock.

Merit Medical Systems Stock Up 0.2%

MMSI stock opened at $91.40 on Thursday. Merit Medical Systems has a twelve month low of $59.74 and a twelve month high of $94.75. The company has a quick ratio of 2.79, a current ratio of 4.20 and a debt-to-equity ratio of 0.44. The stock's 50 day moving average is $88.31 and its 200-day moving average is $76.50. The firm has a market capitalization of $5.46 billion, a PE ratio of 37.77, a P/E/G ratio of 2.28 and a beta of 0.51.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last announced its earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.23. The company had revenue of $418.84 million for the quarter, compared to analysts' expectations of $405.25 million. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%. Merit Medical Systems's quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.01 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. Sell-side analysts expect that Merit Medical Systems will post 3.84 EPS for the current fiscal year.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a medical device company that develops, manufactures and distributes disposable products used in interventional, diagnostic and therapeutic procedures. Its devices are designed for use by healthcare professionals in hospitals, outpatient facilities and other clinical settings.

The company's product portfolio includes devices for vascular access, angiography, intervention, drainage, embolization, oncology and cardiac procedures. Merit also offers products used in peripheral intervention, spine procedures and other specialized areas of minimally invasive medicine, including kits, accessories and related procedural equipment.

Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves healthcare providers through a global commercial and manufacturing network.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.